Biometrics

TheScientificWorldJOURNAL (ISSN 1537-744X)

Article Details

tag at del.icio.us Bookmark this Article Post a Comment Email a friend print document Home  
 
 
  Title: Thermal Ablation of Small Renal Tumors – Present Status
  Authors:   Lovisolo, Jon A.J.; Legramandi, Claudio P.; Fonte, Aldo  
  Journal:   TheScientificWorldJOURNAL  
  Year:   2007  
  Volume:   7  
  Page Range:   756-767  
  Article Type:   Review Article  
  Handling Editor:   Ziya Kirkali  
  Domains:    Oncology ,  Urology  
  DOI:   10.1100/tsw.2007.144  
? Article clouds not enabled. Press the image to enable for this session.
  Keywords:   renal tumors, renal cell carcinoma, ablation, energy ablation, cryotherapy, radiofrequency  
     
 
      Order Article [Related TSW Articles] [Export to EndNote] [Open Choice]  
     

 
      Abstract  
      Thermal ablation of renal tumors is achieved by the delivery of extreme heat or extreme cold directly to the lesion in order to obtain in situ destruction of the malignant cells without having to remove the entire organ. Cryotherapy and radiofrequency ablation are becoming more and more attractive for the treatment of small lesions in select cases. Other types of energy such as microwave, laser and high intensity ultrasound have also been used to destroy kidney lesions but must still be considered in the experimental stage. Cryotherapy and radiofrequency ablation are minimally invasive and have been shown to be safe and effective in treating tumors up to 3 –4 cm in diameter. However, the number of case series is rather limited and follow-up, especially for radiofrequency ablation, is short. Only now are workers beginning to present outcomes after 5 years for cryoablation. Therefore, the long-term oncological efficacy of these ablation techniques remains to be seen. As longer follow-up and greater patient numbers are reported we will get a clearer picture of the true potential of these modalities. Randomized prospective trials would be auspicable. For now, CA and RFA should be limited to few select patients – i.e. patients with comorbidities which render them at high risk for a surgical procedure and possibly patients with genetic conditions such as Von Hippel Lindau disease who will probably develop multiple tumors.  
     
Related articles in:
 
     

 
     
              Post Your Comment Post a Comment
 
     
Post your comments about this paper
No need to register
All comment submissions are monitored. The editor reserves the right to amend or delete any comment. Please ensure your have provided your correct email address: You will receive an email with a link enabling you to edit your comment. Do not use this blog to order this article.
 
Your Full Name:
Your Contact Email:

Please ensure you have provided your correct email address

Comments:
  This Is CAPTCHA Image
For security reasons please enter
the numbers you see in the figure above:
   
 
         
     
tag at del.icio.us Bookmark this Article Post a Comment Email a friend print document Home